Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2017 Q2 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 41 stocks in 2017 Q2, with total market value around $8.75B.
Baupost Group's top five holdings in 2017 Q2: CHENIERE ENERGY INC 11.53%, Synchrony Financial(SYF) 9.98%, VIASAT INC(VSAT) 9.95%, COLONY NORTHSTAR INC 7.71%, ALLERGAN PFD CONV SER A 6.76%.
- Portfolio Value
- $8.75B
- Current Holdings
- 41 stocks
- New / Increased
- 4 / 7
- Reduced / Exited
- 5 / 6
Current Holdings
| 1 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.01 | 11.53% | 20.73 -4.60% | $48.71 | - | $42.98 | -1.00 | 3.50 | +$0.12B+13.34% | Reduced |
| 2 | Synchrony FinancialSYF | 0.87 | 9.98% | 29.30 +65.84% | $29.82 | $72.84 +144.27% | $29.47 | +11.63 | 1.00 | +$1.27B+147.16% | Increased |
| 3 | VIASAT INCVSAT | 0.87 | 9.95% | 13.16 - | $66.20 | - | $70.54 | 0.00 | 4.25 | -$0.06B-6.15% | Held |
| 4 | COLONY NORTHSTAR INCCUSIP 19625W104 | 0.67 | 7.71% | 47.91 - | $14.09 | - | $12.91 | 0.00 | 0.50 | +$0.06B+9.14% | Held |
| 5 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.59 | 6.76% | 2.43 - | $243.09 | - | $354.00 | 0.00 | 1.50 | -$0.27B-31.33% | Held |
| 6 | QORVO INCCUSIP 74736K101 | 0.57 | 6.51% | 9.00 +25.25% | $63.32 | - | $67.50 | +1.81 | 0.50 | -$0.04B-6.20% | Increased |
| 7 | TWENTY FIRST CENTY FOX INC CL AFOXA | 0.54 | 6.20% | 19.14 - | $28.34 | - | $26.77 | 0.00 | 2.00 | +$0.03B+5.85% | Held |
| 8 | ANTERO RES CORPCUSIP 03674X106 | 0.46 | 5.23% | 21.17 +45.95% | $21.61 | - | $16.20 | +6.67 | 3.00 | +$0.11B+33.41% | Increased |
| 9 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.37 | 4.22% | 9.27 - | $39.84 | - | $30.34 | 0.00 | 3.25 | +$0.09B+31.33% | Held |
| 10 | PBF ENERGY INCCUSIP 69318G106 | 0.35 | 4.00% | 15.72 - | $22.26 | - | $25.23 | 0.00 | 4.00 | -$0.05B-11.78% | Held |
| 11 | DELL TECHNOLOGIES INCCUSIP 24703L103 | 0.35 | 3.95% | 5.65 - | $61.11 | - | $47.80 | 0.00 | 1.00 | +$0.08B+27.84% | Held |
| 12 | QUALCOMM IncorporatedQCOM | 0.29 | 3.29% | 5.22 - | $55.22 | $163.45 +196.00% | $57.34 | 0.00 | 0.50 | +$0.55B+185.05% | Held |
| 13 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 0.20 | 2.32% | 7.28 - | $27.87 | - | $27.19 | 0.00 | 2.00 | +$0.00B+2.51% | Held |
| 14 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.19 | 2.13% | 25.79 - | $7.23 | - | $14.16 | 0.00 | 3.50 | -$0.18B-48.95% | Held |
| 15 | EXPRESS SCRIPTS HLDG CO COMESRX | 0.16 | 1.86% | 2.56 +108.11% | $63.84 | - | $64.83 | +1.33 | 0.50 | -$0.00B-1.53% | Increased |
| 16 | CARDINAL HEALTH INCCAH | 0.16 | 1.81% | 2.03 +97.09% | $77.92 | - | $74.90 | +1.00 | 0.75 | +$0.01B+4.03% | Increased |
| 17 | VERITIV CORPCUSIP 923454102 | 0.14 | 1.57% | 3.04 - | $45.00 | - | $46.74 | 0.00 | 3.00 | -$0.01B-3.71% | Held |
| 18 | FORWARD PHARMA A/SCUSIP 34986J105 | 0.13 | 1.48% | 6.36 +14.15% | $20.33 | - | $20.79 | +0.79 | 2.75 | -$0.00B-2.21% | Increased |
| 19 | AVIS BUDGET GROUPCUSIP 053774105 | 0.11 | 1.25% | 4.00 | $27.27 | - | $27.27 | +4.00 | 0.25 | $0.00B0.00% | New |
| 20 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.08 | 0.86% | 5.36 - | $14.00 | - | $31.84 | 0.00 | 2.75 | -$0.10B-56.03% | Held |
| 21 | CHIPMOS TECHNOLOGIES INCCUSIP 16965P103 | 0.07 | 0.79% | 3.51 - | $19.77 | - | $14.11 | 0.00 | 0.75 | +$0.02B+40.11% | Held |
| 22 | SILVER RUN ACQUISITIONCUSIP 82812A103 | 0.07 | 0.77% | 6.62 | $10.13 | - | $10.13 | +6.62 | 0.25 | $0.00B0.00% | New |
| 23 | SPIRIT RLTY CAP INC NEWCUSIP 84860W102 | 0.07 | 0.76% | 9.00 | $7.41 | - | $7.41 | +9.00 | 0.25 | $0.00B0.00% | New |
| 24 | PARATEK PHARMACEUTICALS INCCUSIP 699374302 | 0.06 | 0.66% | 2.39 +17.12% | $24.10 | - | $29.51 | +0.35 | 2.75 | -$0.01B-18.34% | Increased |
| 25 | GTY TECHNOLOGY HOLDINGS INCCUSIP G4182A110 | 0.05 | 0.53% | 4.40 - | $10.46 | - | $10.50 | 0.00 | 0.75 | -$0.00B-0.38% | Held |
Showing 1-25 of 41
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2017 Q2.
| 1 | INNOVIVA INCCUSIP 45781M101 | 11.57 | 1.25 | $12.59 | $13.83 | +$0.01B+9.85% |
| 2 | MCKESSON CORP COMMCK | 1.00 | 0.50 | $140.45 | $148.26 | +$0.01B+5.56% |
| 3 | SILVER RUN ACQUISITIONCUSIP 82812A202 | 6.62 | 0.25 | $10.43 | $10.43 | $0.00B0.00% |
| 4 | LIBERTY VENTURES COMMON STOCKCUSIP 53071M856 | 1.48 | 0.50 | $36.87 | $52.29 | +$0.02B+41.82% |
| 5 | SYNGENTA AGCUSIP 87160A100 | 0.53 | 0.50 | $116.80 | $88.50 | -$0.01B-24.23% |
| 6 | AMERISOURCEBERGEN CORPCUSIP 03073E105 | 0.50 | 0.50 | $78.19 | $88.50 | +$0.01B+13.19% |
Showing 1-6 of 6
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.